Evidence map›Paper›PMID 40755735›Full record

ArticleTranslational gastroenterology and hepatology2025

Higher waist circumference as a risk factor for rebleeding of small bowel angiodysplasia.

Thais Abaurre Haig Santos, Raul Carlos Wahle, Luciane Reis Milani, Milena Arruda de Oliveira Leite, Jaques Waisberg, Paula Bechara Poletti, Fernando Campos Gomes Pinto

Abstract read
In one paragraph

Article in Translational gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Thais Abaurre Haig SantosDepartment of Gastroenterology, "Francisco Morato de Oliveira" State Government Employee Hospital (HSPE-FMO), São Paulo, Brazil.ORCID https://orcid.org/0009-0006-3501-8595
Raul Carlos WahleDepartment of Gastroenterology, "Francisco Morato de Oliveira" State Government Employee Hospital (HSPE-FMO), São Paulo, Brazil.ORCID https://orcid.org/0000-0001-6346-3967
Luciane Reis MilaniDepartment of Gastroenterology, "Francisco Morato de Oliveira" State Government Employee Hospital (HSPE-FMO), São Paulo, Brazil.ORCID https://orcid.org/0000-0003-0474-2725
Milena Arruda de Oliveira LeiteFaculty of Medicine of ABC (FMABC), São Paulo, Brazil.ORCID https://orcid.org/0000-0003-3763-1706
Jaques WaisbergPostgraduate Program in Health Sciences, State Government Employee Medical Assistance Institute (IAMSPE), São Paulo, Brazil.ORCID https://orcid.org/0000-0003-2775-8068
Paula Bechara PolettiDepartment of Gastroenterology, "Francisco Morato de Oliveira" State Government Employee Hospital (HSPE-FMO), São Paulo, Brazil.ORCID https://orcid.org/0000-0001-9896-2176
Fernando Campos Gomes PintoPostgraduate Program in Health Sciences, State Government Employee Medical Assistance Institute (IAMSPE), São Paulo, Brazil.ORCID https://orcid.org/0000-0003-2384-2190

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recurrent bleeding from small bowel angiodysplasia (SBA) is common, and identifying risk factors for rebleeding can help identify high-risk patients who may benefit from further therapy. The pathophysiology of SBA is linked to an imbalance of angiogenic factors such as angiopoietin 1 (Ang-1) and angiopoietin 2 (Ang-2), as well as higher serum levels of Ang-2. Additionally, murine models of steatohepatitis showed elevated serum and hepatic Ang-2 levels, which directly promote pathological angiogenesis. The present study aimed to evaluate risk factors for rebleeding in symptomatic patients with SBA. Methods: Upon review of the medical records and application of the inclusion and exclusion criteria, 109 cases were determined to be affected by SBAs. Five patients were ineligible for the study because of a shorter than one-year follow-up period or early use of a specific treatment. Thus, in a retrospective observational study of 104 patients with gastrointestinal bleeding from SBA between 2012 and 2016 who were conservatively managed at the beginning of follow-up, we obtained clinical features and risk factors for rebleeding, and we analyzed potential predictors of rebleeding through univariate and multivariable analysis. Results: We found that 57 of 104 patients (54.8%) experienced rebleeding during a follow-up of more than one year. The majority were females (71.2%), and we noted that hypertension (70.2%) and dyslipidemia (43.3%) were the most common comorbidities. Multiple regression analysis indicated that waist circumference (WC) (odds ratio for each 1 cm increment =1.04; 95% confidence interval: 1.01-1.08; P=0.02) was a significant risk factor for rebleeding. Conclusions: In patients with symptomatic SBAs, an increase in WC positively correlated with the risk of rebleeding.

Indexed as

angiodysplasiasCapsule endoscopyhemorrhagewaist circumference (WC)

Identifiers

PMID40755735
PMCPMC12314685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.